The Latest Breaking News on Pharma

As immunocompromised people and their families face a third housebound winter, Charlotte Lytton asks why the government is dragging its feet when it comes to the possibly life-altering drug Evusheld. It remains punishingly out of reach… unless you cough up the money for it

SAN DIEGO — You've been free of COVID-19 symptoms for two days. Then the coughing, fatigue and headaches return. Join the growing number of people experiencing what's being called COVID rebound.

Indonesia's food and drug agency said on Monday it had revoked licences for syrup-type drug production by two local firms for violating manufacturing rules, as it investigates the deaths of more than 150 children due to acute kidney injury (AKI).

Research in Africa has found a one-time dose of an experimental drug protected adults against malaria for at least six months

Researchers have created an mRNA-based influenza vaccine that targets four viral proteins that tend to remain the same across different strains of influenza.

Although the stock market has been under pressure this year due to macroeconomic headwinds, the pharmaceutical industry continues to garner investor attention as it enjoys inelastic demand for its products regardless of economic conditions. Thus, fundamentally-sound pharma stocks Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) could be worth your attention…

The monkeypox response in rural areas is hindered by patchy resources and bitter politics

Small Pharma Inc.

The head of the U.S. Centers for Disease Control and Prevention has tested positive again for COVID-19

Company which specialises in diagnostic tools has been sold by its PE backers after an 11-year relationship

JAKARTA: Indonesia's food and drug agency (BPOM) said on Monday it had revoked licenses of syrup-type drug production of two local firms for violating manufacturing rules, as it probes the deaths of more than 150 children due to acute kidney injury (AKI).